Invicare Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 6

Invicare General Information

Description

Developer of nanocrystalline biomaterials designed to prevent and treat dental implant infections. The company offers biomaterials that provide dental implant cleaning, infection prevention, and infection treatment capabilities using proprietary inorganic crystalline hydrogels, enabling dental professionals to improve implant care and support better treatment outcomes.

Contact Information

Website
www.invicare.ca
Formerly Known As
2D-CrystaLab
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 1250 Rue Guy
  • Suite 600
  • Montreal, Quebec H3H 2R7
  • Canada
+1 (438)
Primary Industry
Biotechnology
Other Industries
Therapeutic Devices
Medical Supplies
Corporate Office
  • 1250 Rue Guy
  • Suite 600
  • Montreal, Quebec H3H 2R7
  • Canada
+1 (438)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Invicare Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Accelerator/Incubator 23-Jun-2021 Completed Generating Revenue
7. Accelerator/Incubator Completed Generating Revenue
6. Angel (individual) 01-Feb-2021 Completed Generating Revenue
5. Angel (individual) 11-Oct-2018 Completed Generating Revenue
4. Accelerator/Incubator 01-Jan-2018 Completed Generating Revenue
3. Accelerator/Incubator 01-Jan-2018 Completed Generating Revenue
2. Accelerator/Incubator 27-Feb-2017 Completed Generating Revenue
1. University Spin-Out 01-Jan-2017 Completed Generating Revenue
To view Invicare’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Invicare Patents

Invicare Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2024082070-A1 Bone implant with a magnesium phosphate xerogel coating Inactive 21-Oct-2022
EP-3386547-A1 Magnesium phosphate hydrogels Active 10-Dec-2015
EP-3386547-A4 Magnesium phosphate hydrogels Active 10-Dec-2015
EP-3386547-B1 Magnesium phosphate hydrogels Active 10-Dec-2015
EP-4104864-A1 Magnesium phosphate hydrogels Active 10-Dec-2015 C01B25/45
To view Invicare’s complete patent history, request access »

Invicare Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Invicare Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Medical Alley Association Accelerator/Incubator Minority
Centech Accelerator Accelerator/Incubator
McGill Dobson Centre for Entrepreneurship Accelerator/Incubator Minority
McGill X-1 Accelerator Accelerator/Incubator
McGill University University
You’re viewing 5 of 6 investors. Get the full list »

Invicare FAQs

  • When was Invicare founded?

    Invicare was founded in 2017.

  • Where is Invicare headquartered?

    Invicare is headquartered in Montreal, Canada.

  • What is the size of Invicare?

    Invicare has 3 total employees.

  • What industry is Invicare in?

    Invicare’s primary industry is Biotechnology.

  • Is Invicare a private or public company?

    Invicare is a Private company.

  • What is Invicare’s current revenue?

    The current revenue for Invicare is .

  • Who are Invicare’s investors?

    Medical Alley Association, Centech Accelerator, McGill Dobson Centre for Entrepreneurship, McGill X-1 Accelerator, and McGill University are 5 of 6 investors who have invested in Invicare.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process